These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 25494645)

  • 21. Integrative genomic approaches to dissect clinically-significant relationships between the VDR cistrome and gene expression in primary colon cancer.
    Long MD; Campbell MJ
    J Steroid Biochem Mol Biol; 2017 Oct; 173():130-138. PubMed ID: 28027912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA regulates human vitamin D receptor.
    Mohri T; Nakajima M; Takagi S; Komagata S; Yokoi T
    Int J Cancer; 2009 Sep; 125(6):1328-33. PubMed ID: 19437538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of 1,25(OH)2D3, 25OHD3, and EB1089 on cell growth and Vitamin D receptor mRNA and 1alpha-hydroxylase mRNA expression in primary cultures of the canine prostate.
    Kunakornsawat S; Rosol TJ; Capen CC; Omdahl JL; Leroy BE; Inpanbutr N
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):409-12. PubMed ID: 15225811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mineralization of three-dimensional osteoblast cultures is enhanced by the interaction of 1α,25-dihydroxyvitamin D3 and BMP2 via two specific vitamin D receptors.
    Chen J; Dosier CR; Park JH; De S; Guldberg RE; Boyan BD; Schwartz Z
    J Tissue Eng Regen Med; 2016 Jan; 10(1):40-51. PubMed ID: 23784946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
    Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF
    Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LSD1 dual function in mediating epigenetic corruption of the vitamin D signaling in prostate cancer.
    Battaglia S; Karasik E; Gillard B; Williams J; Winchester T; Moser MT; Smiraglia DJ; Foster BA
    Clin Epigenetics; 2017; 9():82. PubMed ID: 28811844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integration of microRNA signatures of distinct mammary epithelial cell types with their gene expression and epigenetic portraits.
    Pal B; Chen Y; Bert A; Hu Y; Sheridan JM; Beck T; Shi W; Satterley K; Jamieson P; Goodall GJ; Lindeman GJ; Smyth GK; Visvader JE
    Breast Cancer Res; 2015 Jun; 17(1):85. PubMed ID: 26080807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DC-SCRIPT: AR and VDR regulator lost upon transformation of prostate epithelial cells.
    Ansems M; Karthaus N; Hontelez S; Aalders T; Looman MW; Verhaegh GW; Schalken JA; Adema GJ
    Prostate; 2012 Dec; 72(16):1708-17. PubMed ID: 22473304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines.
    Skowronski RJ; Peehl DM; Feldman D
    Endocrinology; 1993 May; 132(5):1952-60. PubMed ID: 7682937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. VDR primary targets by genome-wide transcriptional profiling.
    Goeman F; De Nicola F; D'Onorio De Meo P; Pallocca M; Elmi B; Castrignanò T; Pesole G; Strano S; Blandino G; Fanciulli M; Muti P
    J Steroid Biochem Mol Biol; 2014 Sep; 143():348-56. PubMed ID: 24726990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNAs and zinc metabolism-related gene expression in prostate cancer cell lines treated with zinc(II) ions.
    Hlavna M; Raudenska M; Hudcova K; Gumulec J; Sztalmachova M; Tanhäuserova V; Babula P; Adam V; Eckschlager T; Kizek R; Masarik M
    Int J Oncol; 2012 Dec; 41(6):2237-44. PubMed ID: 23064315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperresponsiveness of vitamin D receptor gene expression to 1,25-dihydroxyvitamin D3. A new characteristic of genetic hypercalciuric stone-forming rats.
    Yao J; Kathpalia P; Bushinsky DA; Favus MJ
    J Clin Invest; 1998 May; 101(10):2223-32. PubMed ID: 9593778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 1α,25(OH)2D3 differentially regulates miRNA expression in human bladder cancer cells.
    Ma Y; Hu Q; Luo W; Pratt RN; Glenn ST; Liu S; Trump DL; Johnson CS
    J Steroid Biochem Mol Biol; 2015 Apr; 148():166-71. PubMed ID: 25263658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitamin D receptor activation down-regulates the small heterodimer partner and increases CYP7A1 to lower cholesterol.
    Chow EC; Magomedova L; Quach HP; Patel R; Durk MR; Fan J; Maeng HJ; Irondi K; Anakk S; Moore DD; Cummins CL; Pang KS
    Gastroenterology; 2014 Apr; 146(4):1048-59. PubMed ID: 24365583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.
    Chow EC; Quach HP; Vieth R; Pang KS
    Am J Physiol Endocrinol Metab; 2013 May; 304(9):E977-89. PubMed ID: 23482451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipopolysaccharide negatively modulates vitamin D action by down-regulating expression of vitamin D-induced VDR in human monocytic THP-1 cells.
    Pramanik R; Asplin JR; Lindeman C; Favus MJ; Bai S; Coe FL
    Cell Immunol; 2004; 232(1-2):137-43. PubMed ID: 15876428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of proliferation and induction of apoptosis by 25-hydroxyvitamin D3-3beta-(2)-Bromoacetate, a nontoxic and vitamin D receptor-alkylating analog of 25-hydroxyvitamin D3 in prostate cancer cells.
    Swamy N; Chen TC; Peleg S; Dhawan P; Christakos S; Stewart LV; Weigel NL; Mehta RG; Holick MF; Ray R
    Clin Cancer Res; 2004 Dec; 10(23):8018-27. PubMed ID: 15585637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Minireview: vitamin D receptor: new assignments for an already busy receptor.
    Norman AW
    Endocrinology; 2006 Dec; 147(12):5542-8. PubMed ID: 16946007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.
    Sertznig P; Dunlop T; Seifert M; Tilgen W; Reichrath J
    Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of VDR-responsive gene signatures in breast cancer cells.
    Towsend K; Trevino V; Falciani F; Stewart PM; Hewison M; Campbell MJ
    Oncology; 2006; 71(1-2):111-23. PubMed ID: 17377416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.